Yuqing Xie

2.3k total citations · 3 hit papers
31 papers, 1.4k citations indexed

About

Yuqing Xie is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yuqing Xie has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Yuqing Xie's work include Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Yuqing Xie is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Yuqing Xie collaborates with scholars based in China, Switzerland and United States. Yuqing Xie's co-authors include Li Tang, Darrell J. Irvine, Yiran Zheng, Marcela V. Maus, Ana P. Castaño, Llian Mabardi, Sagar B. Kudchodkar, Emily K. Jeng, Na Li and Mariane B. Melo and has published in prestigious journals such as Science, Nucleic Acids Research and Nature Biotechnology.

In The Last Decade

Yuqing Xie

27 papers receiving 1.4k citations

Hit Papers

Enhancing T cell therapy through TCR-signaling-responsive... 2018 2026 2020 2023 2018 2021 2024 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
    2018 542 citations Li Tang, Yiran Zheng et al. Nature Biotechnology profile →
  2. Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy
    2021 176 citations Kewen Lei, Armand Kurum et al. Nature Biomedical Engineering profile →
  3. IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
    2024 144 citations Yang Zhao, Jiangqing Chen et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuqing Xie China 14 603 530 522 461 187 31 1.4k
John W. Hickey United States 18 592 1.0× 460 0.9× 527 1.0× 879 1.9× 221 1.2× 48 1.9k
Novalia Pishesha United States 19 699 1.2× 293 0.6× 567 1.1× 803 1.7× 87 0.5× 32 1.8k
Kyle C. Roche United States 14 556 0.9× 828 1.6× 540 1.0× 550 1.2× 410 2.2× 20 1.6k
Karlo Perica United States 17 1.1k 1.8× 513 1.0× 1.1k 2.2× 600 1.3× 237 1.3× 29 2.0k
Juliana Hamzah Australia 21 599 1.0× 281 0.5× 628 1.2× 736 1.6× 200 1.1× 37 1.7k
Edwin R. Manuel United States 20 480 0.8× 343 0.6× 468 0.9× 466 1.0× 61 0.3× 39 1.3k
Ashish Kulkarni United States 24 696 1.2× 702 1.3× 306 0.6× 674 1.5× 275 1.5× 56 1.7k
Taek-Chin Cheong United States 14 382 0.6× 262 0.5× 216 0.4× 621 1.3× 161 0.9× 22 1.2k
Jason Y.H. Chang United States 15 461 0.8× 292 0.6× 357 0.7× 429 0.9× 74 0.4× 24 1.3k
Sabina Pozzi Israel 13 282 0.5× 501 0.9× 319 0.6× 367 0.8× 196 1.0× 24 1.1k

Countries citing papers authored by Yuqing Xie

Since Specialization
Citations

This map shows the geographic impact of Yuqing Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuqing Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuqing Xie more than expected).

Fields of papers citing papers by Yuqing Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuqing Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuqing Xie. The network helps show where Yuqing Xie may publish in the future.

Co-authorship network of co-authors of Yuqing Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yuqing Xie. A scholar is included among the top collaborators of Yuqing Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuqing Xie. Yuqing Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Yuqing, et al.. (2025). Synthetic closed-loop gene circuit for phenylalanine regulation. Nucleic Acids Research. 53(20).
2.
Xie, Yuqing, et al.. (2025). A closed-loop cholesterol shunt controlling experimental dyslipidemia. Cell Metabolism. 37(10). 2066–2075.e3.
3.
4.
Zhao, Yang, Jiangqing Chen, Massimo Andreatta, et al.. (2024). IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases. Nature Biotechnology. 42(11). 1693–1704. 144 indexed citations breakdown →
5.
Liang, Yuling, Yuqing Xie, Zhibo Dang, et al.. (2024). Yiqi Liangxue Jiedu Prescription Inhibited the Canonical Wnt Pathway to Prevent Hepatocellular Precancerous Lesions. Journal of Hepatocellular Carcinoma. Volume 11. 2293–2308.
6.
Huang, Jinbo, Shuai Xue, Yuqing Xie, Ana P. Teixeira, & Martin Fussenegger. (2024). Ultrashort‐Peptide‐Responsive Gene Switches for Regulation of Therapeutic Protein Expression in Mammalian Cells. Advanced Science. 11(28). e2309411–e2309411. 8 indexed citations
7.
Yu, Lihua, et al.. (2024). Prognostic value of CD8+T cells related genes and exhaustion regulation of Notch signaling pathway in hepatocellular carcinoma. Frontiers in Immunology. 15. 1375864–1375864. 3 indexed citations
8.
9.
Yu, Lihua, et al.. (2022). Establishment of Nomogram Model for Minimally Invasive Treatment of Small Hepatocellular Carcinoma Based on CD8+T Cell Counts. OncoTargets and Therapy. Volume 15. 925–940. 2 indexed citations
10.
Xie, Yuqing, Fengna Yan, Xinhui Wang, et al.. (2022). Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma. Cancer Medicine. 12(3). 3237–3259. 8 indexed citations
11.
12.
Yu, Lihua, Xiaoli Liu, Xinhui Wang, et al.. (2022). Nomogram for prediction of long-term survival with hepatocellular carcinoma based on NK cell counts. Annals of Hepatology. 27(2). 100672–100672. 2 indexed citations
13.
Xie, Yuqing, Simon Van Herck, Sina Nassiri, et al.. (2021). Switchable immune modulator for tumor-specific activation of anticancer immunity. Science Advances. 7(37). eabg7291–eabg7291. 36 indexed citations
14.
Lei, Kewen, Armand Kurum, Murat Kaynak, et al.. (2021). Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy. Nature Biomedical Engineering. 5(12). 1411–1425. 176 indexed citations breakdown →
15.
Gao, Min, Yuqing Xie, Kewen Lei, et al.. (2021). A Manganese Phosphate Nanocluster Activates the cGAS‐STING Pathway for Enhanced Cancer Immunotherapy. Advanced Therapeutics. 4(8). 56 indexed citations
16.
Yan, Fengna, Miaomiao Feng, Xinhui Wang, et al.. (2020). Molecular targets of Yangyin Fuzheng Jiedu Prescription in the treatment of hepatocellular carcinoma based on network pharmacology analysis. Cancer Cell International. 20(1). 540–540. 11 indexed citations
17.
Xie, Yuqing, Lixia Wei, Yiran Zheng, et al.. (2019). Redox-responsive interleukin-2 nanogel specifically and safely promotes the proliferation and memory precursor differentiation of tumor-reactive T-cells. Biomaterials Science. 7(4). 1345–1357. 79 indexed citations
18.
Tang, Li, Yiran Zheng, Mariane B. Melo, et al.. (2018). Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery. Nature Biotechnology. 36(8). 707–716. 542 indexed citations breakdown →
19.
Xu, Zhengzhong, Xin Li, Shanshan Jin, et al.. (2018). Rapid loss of early antigen-presenting activity of lymph node dendritic cells against Ag85A protein following Mycobacterium bovis BCG infection. BMC Immunology. 19(1). 19–19. 3 indexed citations
20.
Xie, Yuqing, Hongdi Ma, & Zhe‐Xiong Lian. (2015). Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity. Clinical Reviews in Allergy & Immunology. 50(3). 390–403. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John W. Hickey Breakdown of academic impact, for papers by Novalia Pishesha Breakdown of academic impact, for papers by Kyle C. Roche Breakdown of academic impact, for papers by Karlo Perica Breakdown of academic impact, for papers by Juliana Hamzah Breakdown of academic impact, for papers by Edwin R. Manuel Breakdown of academic impact, for papers by Ashish Kulkarni Breakdown of academic impact, for papers by Taek-Chin Cheong Breakdown of academic impact, for papers by Jason Y.H. Chang Breakdown of academic impact, for papers by Sabina Pozzi
Rankless by CCL
2026